P, H., E, B., JB, H., & M, A. (2021). Efficacy of Brodalumab and Guselkumab in Patients with Moderate-to-Severe Plaque Psoriasis Who are Inadequate Responders to Ustekinumab: A Matching Adjusted Indirect Comparison. Dove Medical Press.
Style de citation Chicago (17e éd.)P, Hampton, Borg E, Hansen JB, et Augustin M. Efficacy of Brodalumab and Guselkumab in Patients with Moderate-to-Severe Plaque Psoriasis Who Are Inadequate Responders to Ustekinumab: A Matching Adjusted Indirect Comparison. Dove Medical Press, 2021.
Style de citation MLA (8e éd.)P, Hampton, et al. Efficacy of Brodalumab and Guselkumab in Patients with Moderate-to-Severe Plaque Psoriasis Who Are Inadequate Responders to Ustekinumab: A Matching Adjusted Indirect Comparison. Dove Medical Press, 2021.
Attention : ces citations peuvent ne pas être correctes à 100%.